Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China
· Delayed Price · Currency is CNY 28.90
-0.52 (-1.77%)
Jun 17, 2025, 2:45 PM CST
SHA:688393 Market Cap
SHA:688393 has a market cap or net worth of 2.75 billion as of June 17, 2025. Its market cap has increased by 58.86% in one year.
Market Cap
2.75B
Enterprise Value
2.64B
Revenue
441.86M
Ranking
n/a
PE Ratio
1,230.28
Stock Price
28.90
Market Cap Chart
Since August 20, 2020, SHA:688393's market cap has decreased from 5.65B to 2.75B, a decrease of -51.24%. That is a compound annual growth rate of -13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 2.75B | 69.96% |
| Dec 31, 2024 | 1.62B | -30.68% |
| Dec 29, 2023 | 2.34B | 13.78% |
| Dec 30, 2022 | 2.05B | -27.80% |
| Dec 31, 2021 | 2.84B | -17.60% |
| Dec 31, 2020 | 3.45B | -38.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 357.20B |
| Shenzhen Mindray Bio-Medical Electronics | 286.96B |
| WuXi AppTec | 196.82B |
| Sichuan Biokin Pharmaceutical | 130.53B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.53B |
| Aier Eye Hospital Group | 113.59B |
| Shanghai United Imaging Healthcare | 106.19B |
| Yunnan Baiyao Group Co.,Ltd | 100.81B |